Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

302
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
302
Distribution of Molecular Speeds01:27

Distribution of Molecular Speeds

5.8K
The motion of molecules in a gas is random in magnitude and direction for individual molecules, but a gas of many molecules has a predictable distribution of molecular speeds. This predictable distribution of molecular speeds is known as the Maxwell-Boltzmann distribution. The distribution of molecular speeds in liquids is comparable to that of gases but not identical and can help to understand the phenomenon of the boiling and vapor pressure of a liquid. Consider that a molecule requires a...
5.8K
Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models00:57

Physiological Pharmacokinetic Models: Blood Flow-Limited Versus Diffusion-Limited Models

418
Physiological pharmacokinetic models, often called flow-limited or perfusion models, typically assume a swift drug distribution between tissue and venous blood, creating a rapid drug equilibrium. This premise is based on the idea that drug diffusion is extremely fast, and the cell membrane presents no barrier to drug permeation. In this scenario, where no drug binding occurs, the drug concentration in the tissue equals that of the venous blood leaving the tissue. This greatly simplifies the...
418
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

384
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
384
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

676
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
676
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

628
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
628

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CODE beyond FAIR: a roadmap for reusable research software.

Scientific data·2026
Same author

Simulation and generalized Langevin equation study of lipid subdiffusion in biomembrane phases.

Biophysical journal·2025
Same author

Stop treating code like an afterthought: record, share and value it.

Nature·2025
Same author

Software in science is ubiquitous yet overlooked.

Nature computational science·2024
Same author

Signature of functional enzyme dynamics in quasielastic neutron scattering spectra: The case of phosphoglycerate kinase.

The Journal of chemical physics·2023
Same author

Quasi-analytical resolution-correction of elastic neutron scattering from proteins.

The Journal of chemical physics·2022

Related Experiment Video

Updated: Mar 13, 2026

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules
10:20

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules

Published on: September 5, 2019

8.9K

Communication: A multiscale Bayesian inference approach to analyzing subdiffusion in particle trajectories.

Konrad Hinsen1, Gerald R Kneller1

  • 1Centre de Biophysics. Moléculaire, CNRS, Rue Charles Sadron, 45071 Orléans, France.

The Journal of Chemical Physics
|October 27, 2016
PubMed
Summary

Detecting anomalous diffusion in finite trajectories is challenging. This study introduces a Bayesian inference method for accurate analysis of particle movement, even with limited data.

More Related Videos

Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy
12:15

Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy

Published on: April 9, 2019

9.3K
High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
15:13

High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy

Published on: July 25, 2014

11.9K

Related Experiment Videos

Last Updated: Mar 13, 2026

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules
10:20

Single-Molecule Tracking Microscopy - A Tool for Determining the Diffusive States of Cytosolic Molecules

Published on: September 5, 2019

8.9K
Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy
12:15

Image Processing Protocol for the Analysis of the Diffusion and Cluster Size of Membrane Receptors by Fluorescence Microscopy

Published on: April 9, 2019

9.3K
High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
15:13

High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy

Published on: July 25, 2014

11.9K

Area of Science:

  • Physics
  • Physical Chemistry
  • Biophysics

Background:

  • Anomalous diffusion exhibits complex asymptotic behavior (t → ∞).
  • Finite-length experimental or simulation trajectories hinder accurate detection and characterization of anomalous diffusion.
  • Understanding particle dynamics is crucial in various scientific fields.

Purpose of the Study:

  • To develop a novel method for robustly detecting and describing anomalous diffusion from finite trajectories.
  • To apply Bayesian inference directly to observed particle trajectories across multiple time scales.
  • To validate the proposed method using simulated data and analyze real biological systems.

Main Methods:

  • Bayesian inference framework applied to particle trajectory data.
  • Analysis of trajectories sampled at different time scales.
  • Validation using random walk simulations with known statistical properties.

Main Results:

  • The proposed Bayesian approach accurately detects anomalous diffusion in finite-length trajectories.
  • The method effectively characterizes diffusion properties across various time scales.
  • Successful application to analyze lipid molecule motion in a lipid bilayer.

Conclusions:

  • Bayesian inference offers a powerful tool for analyzing anomalous diffusion in practical scenarios.
  • The developed method overcomes limitations of traditional approaches for finite trajectory data.
  • This technique enhances the understanding of molecular dynamics in biological membranes.